Literature DB >> 17622720

Transient global amnesia--full recovery without persistent cognitive impairment.

I Uttner1, S Weber, W Freund, B Schmitz, M Ramspott, R Huber.   

Abstract

Transient global amnesia (TGA) is a clinical syndrome of unknown etiology characterized by sudden onset anterograde amnesia, which was thought to resolve completely. However, some authors have also suggested permanent memory impairment. It is unclear whether these results reflect a true persistent damage or a simply too short assessment interval in the context of a prolonged recovery phase after TGA. To evaluate the cognitive long-term outcome, 16 patients who had suffered from TGA at a mean of 3 years before and 15 healthy controls underwent a comprehensive neuropsychological test battery. No significant differences between patients' and controls' cognitive performance were found, irrespectively of the analyzed neuropsychological domain. Therefore we hypothesize that TGA usually does not cause persistent cognitive deficits due to a generally transient and prognostic benign character. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17622720     DOI: 10.1159/000104715

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

Review 1.  Transient amnesic syndromes.

Authors:  Thorsten Bartsch; Christopher Butler
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

2.  Stronger pharmacological cortisol suppression and anticipatory cortisol stress response in transient global amnesia.

Authors:  Martin Griebe; Frauke Nees; Benjamin Gerber; Anne Ebert; Herta Flor; Oliver T Wolf; Achim Gass; Michael G Hennerici; Kristina Szabo
Journal:  Front Behav Neurosci       Date:  2015-03-09       Impact factor: 3.558

Review 3.  Forgetting the Unforgettable: Transient Global Amnesia Part II: A Clinical Road Map.

Authors:  Marco Sparaco; Rosario Pascarella; Carmine Franco Muccio; Marialuisa Zedde
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.